Impulsive Behavior: Clinical Trials

2 trials for Impulsive Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Withdrawn 2

Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis
Standard Varenicline Dosing (1 mg BID), Bupropion 150 mg twice daily, Increased Varenicline Dosing (1mg TID) - Pancreatitis, Chronic, Pancreatitis, Acute
Phase 2WithdrawnMayo Clinic2025-11-062026-07-07
Transcranial Direct Current Stimulation in a Smoking Cessation Trial
active transcranial Direct Current Stimulation, sham transcranial Direct Current Stimulation - Nicotine Dependence
Phase 2WithdrawnCentre for Addiction and Mental Health2016-10-012016-06-13

Narrower conditions

Behavior, Addictive (2)  ·  Smoking Cessation (2)  ·  Pancreatitis (1)  ·  Pancreatitis, Chronic (1)  ·  Smoking (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Behavior (2)  ·  Compulsive Behavior (2)  ·  Health Behavior (2)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Mental Disorders (1)  ·  Pancreatic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

BID protein, human (1)  ·  Bupropion (1)

Sponsors

Centre for Addiction and Mental Health (1)  ·  Mayo Clinic (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Laurie Zawertailo, Ph.D. (1)  ·  Samuel Han, MD (1)